208 related articles for article (PubMed ID: 15159697)
21. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
22. Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders.
Gorobets LN
Bull Exp Biol Med; 2005 Dec; 140(6):714-5. PubMed ID: 16848233
[TBL] [Abstract][Full Text] [Related]
23. Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
Sumiyoshi T; Higuchi Y; Matsui M; Arai H; Takamiya C; Meltzer HY; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):965-7. PubMed ID: 17391821
[No Abstract] [Full Text] [Related]
24. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
Smith S; Wheeler MJ; Murray R; O'Keane V
J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
[TBL] [Abstract][Full Text] [Related]
26. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
[TBL] [Abstract][Full Text] [Related]
27. Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.
Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty T; Gangadhar BN
Schizophr Res; 2010 Jun; 119(1-3):131-7. PubMed ID: 20226630
[TBL] [Abstract][Full Text] [Related]
28. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Kapur S; Remington G
Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
[TBL] [Abstract][Full Text] [Related]
29. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Sacchetti E; Valsecchi P; Parrinello G;
Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
[TBL] [Abstract][Full Text] [Related]
30. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
[TBL] [Abstract][Full Text] [Related]
31. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
Khouzam HR
Depress Anxiety; 2000; 11(2):80-2. PubMed ID: 10812533
[TBL] [Abstract][Full Text] [Related]
32. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study.
Araki T; Kasai K; Rogers MA; Kato N; Iwanami A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1083-90. PubMed ID: 16723179
[TBL] [Abstract][Full Text] [Related]
33. Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?
O'Keane V; Meaney AM
J Clin Psychopharmacol; 2005 Feb; 25(1):26-31. PubMed ID: 15643097
[TBL] [Abstract][Full Text] [Related]
34. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Keefe RS; Bilder RM; Davis SM; Harvey PD; Palmer BW; Gold JM; Meltzer HY; Green MF; Capuano G; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Davis CE; Hsiao JK; Lieberman JA; ;
Arch Gen Psychiatry; 2007 Jun; 64(6):633-47. PubMed ID: 17548746
[TBL] [Abstract][Full Text] [Related]
35. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
[TBL] [Abstract][Full Text] [Related]
36. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
[TBL] [Abstract][Full Text] [Related]
37. A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.
Yoshimura M; Koenig T; Irisawa S; Isotani T; Yamada K; Kikuchi M; Okugawa G; Yagyu T; Kinoshita T; Strik W; Dierks T
Psychopharmacology (Berl); 2007 May; 191(4):995-1004. PubMed ID: 17333135
[TBL] [Abstract][Full Text] [Related]
38. Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients.
Markianos M; Hatzimanolis J; Lykouras L
Eur Neuropsychopharmacol; 1999 Dec; 9(6):533-6. PubMed ID: 10625122
[TBL] [Abstract][Full Text] [Related]
39. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
Liu-Seifert H; Adams DH; Kinon BJ
BMC Med; 2005 Dec; 3():21. PubMed ID: 16375765
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]